As President and CEO of JDRF, a global leader in type 1 diabetes (T1D) research and advocacy, Dr. Kowalski drives strategies to accelerate progress toward cures and turn breakthroughs into technologies and therapies that help people stay healthy until then.

Dr. Kowalski’s scientific expertise, his personal experience of living with T1D for over 35 years, and his ability to engage the T1D community enable him to advance JDRF’s mission to cure, prevent, and treat T1D and its complications. He joined JDRF in 2004 and most recently served as Chief Mission Officer.

As an internationally recognized scientific expert, he was pivotal in the transformation of JDRF’s role as the leading global organization funding T1D research, from an organization funding primarily academic research to a highly engaged strategic funder influencing the research and development pipeline. Under his leadership, JDRF is known for collaboration across the international T1D community – working closely with senior industry executives and leaders in academia, clinical care and government.